A rare genetic disorder caused by the accumulation of glucocerebroside in cells of the macrophage-monocyte system, owing to the lack of the glucocerebrosidase enzyme, Gaucher primarily affects the liver and the spleen. The disease manifests as Type 1, the most common form, also known as...
The American Cancer society estimates that in 2019, there will be around 22,530 new diagnoses of Ovarian Cancer and 13,980 women will succumb to the disease. It is the fifth largest cause for death in women, with over 1 in 78 chances of acquiring this...
Methylmalonic Acidemia, a rare inherited disease that occurs in an estimated 1 in 50,000 to 100,000 people, is characterized by the inability of the body to process proteins and lipids effectively. This disease mostly affects infants leading to hypotonia, hepatomegaly and in severe cases failure...
Rosacea affects over 415 million people worldwide, and more than 16 million in the U.S alone, according to research conducted by the University of Copenhagen, Denmark. It is a fairly common skin disorder, but only 18 percent of Americans afflicted with this condition are under...
Puma Biotechnology (NASDAQ: PBYI), a biopharmaceutical company focused on Oncology, announced the submission of a supplemental New Drug Application (sNDA) to the FDA, for neratinib in combination with capecitabine for treatment of HER2-positive metastatic breast cancer in patients who have failed two or more prior...
IntriCon Corporation (NASDAQ: IIN), a developer, manufacturer and distributor of miniature body-worn devices in the hearing healthcare and medical biotelemetry field, has secured a four-year Supply Agreement with Medtronic (NYSE: MDT), one of its largest customers. Medtronic is the market leader in Continuous Glucose Monitoring...
Narcolepsy is a sleep disorder that affects 1 in 2000 individuals and is caused by the loss or damage of a chemical named Hypocretin present in the hypothalamus, which is responsible for the regulation of sleep cycles and alerting the brain. This disorder is characterized...
There is never a dull day in the Cannabis Industry! Each day brings news of consolidations, expansions and diversification of established as well new entrants in the cannabis space, eager to make gains, in the possible event of legalization of Cannabis in the U.S. This year...
Earlier this year, we had covered some path-breaking companies engaged in clinical trials, to test the efficacy and safety of novel therapeutics, which could help in the treatment and management of Duchenne Muscular Dystrophy (DMD). Capricor Therapeutics, (NASDAQ: CAPR) a clinical-stage biotechnology company at the forefront...
Medigus Ltd, (NASDAQ:MDGS) a pioneer in developing cutting-edge minimally invasive surgical tools and imaging solutions for medical as well as industrial use, announced that the company, along with A.M surgical has landed a “Substantial Commercial Order” for manufacturing 1,400 units of its integrated visualization device...
